Keren Osman, MD
- ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Specialties:
Hematology-Oncology, Cancer (Oncology)Keren Osman, MD, is Associate Professor of Medicine, Hematology and Medical Oncology, at the Icahn School of Medicine at Mount Sinai (ISMMS). She is the Medical Director of the Cellular Therapy Service in the Bone Marrow and Stem Cell Transplantation Program at The Tisch Cancer Institute and The Mount Sinai Hospital. Before joining the faculty at Mount Sinai, Dr. Osman spent three years as a Clinical Scholar in a Tumor Immunology Laboratory at The Rockefeller University, where she studied dendritic cell vaccines for the treatment of advanced cancers. Dr. Osman specializes in AL amyloidosis and cellular therapy applications, including CAR T-cell therapy, for the treatment of advanced blood and solid tumor cancers.
Learn more about the Cellular Therapy Service here: https://www.mountsinai.org/care/cancer/treatments/cellular-therapy
Videos
Clinical Focus
- AL Amyloidosis
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- Adult Non-Hodgkin's Lymphoma
- Bone Marrow Transplantation
- Bone Marrow Transplantation, Allogeneic
- Bone Marrow Transplantation, Autologous
- Hematologic Malignancies
- Hematology
- Hodgkin's Disease
- Hodgkin's Lymphoma
- Leukemia
- Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myelofibrosis
- Transplantation
Education
MD, Westmed Medical Group
Residency, Internal Medicine, Mount Sinai Hospital
Fellowship, Medical Oncology, Memorial Sloan-Kettering Cancer Center
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Osman did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.